142 related articles for article (PubMed ID: 23871804)
1. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
Lin ZY; Wu CC; Chuang YH; Chuang WL
Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
Lin ZY; Chuang YH; Chuang WL
Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
Lin ZY; Chuang WL
Biomed Pharmacother; 2010 May; 64(5):348-51. PubMed ID: 19932582
[TBL] [Abstract][Full Text] [Related]
5. Clinically acceptable colchicine concentrations have potential for the palliative treatment of human cholangiocarcinoma.
Wu CC; Lin ZY; Kuoc CH; Chuang WL
Kaohsiung J Med Sci; 2015 May; 31(5):229-34. PubMed ID: 25910557
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines.
Lin ZY; Kuo CH; Wu DC; Chuang WL
Kaohsiung J Med Sci; 2016 Feb; 32(2):68-73. PubMed ID: 26944324
[TBL] [Abstract][Full Text] [Related]
7. High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
Lin ZY; Chuang WL
Biomed Pharmacother; 2012 Dec; 66(8):583-6. PubMed ID: 23089469
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines.
Lin ZY; Chuang WL; Chuang YH
Eur J Clin Invest; 2009 Mar; 39(3):239-45. PubMed ID: 19260954
[TBL] [Abstract][Full Text] [Related]
9. Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients.
Lin ZY; Chuang WL
Biomed Pharmacother; 2017 Feb; 86():27-31. PubMed ID: 27936391
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
11. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
12. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
[TBL] [Abstract][Full Text] [Related]
13. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
[TBL] [Abstract][Full Text] [Related]
14. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
[TBL] [Abstract][Full Text] [Related]
15. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the Chinese traditional medicinal herb Celastrus orbiculatus Thunb on human hepatocellular carcinoma in an orthothopic fluorescent nude mouse model.
Wang M; Zhang X; Xiong X; Yang Z; Sun Y; Yang Z; Hoffman RM; Liu Y
Anticancer Res; 2012 Apr; 32(4):1213-20. PubMed ID: 22493351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
